(Q33708210)

28 July 2017

title

Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157. (English)

1 reference

28 July 2017

1

Joanna S Fowler

1 reference

28 July 2017

11

Gene-Jack Wang

1 reference

28 July 2017

Jean Logan

2

1 reference

28 July 2017

Albert J Azzaro

3

1 reference

28 July 2017

Robert M Fielding

4

1 reference

28 July 2017

Wei Zhu

5

1 reference

28 July 2017

Amy K Poshusta

6

1 reference

28 July 2017

Daniel Burch

7

1 reference

28 July 2017

Barry Brand

8

1 reference

28 July 2017

James Free

9

1 reference

28 July 2017

Mahnaz Asgharnejad

10

1 reference

28 July 2017

Frank Telang

12

1 reference

28 July 2017

Barbara Hubbard

13

1 reference

28 July 2017

Millard Jayne

14

1 reference

28 July 2017

Payton King

15

1 reference

28 July 2017

Pauline Carter

16

1 reference

28 July 2017

Scott Carter

17

1 reference

28 July 2017

Youwen Xu

18

1 reference

28 July 2017

Colleen Shea

19

1 reference

28 July 2017

Lisa Muench

20

1 reference

28 July 2017

David Alexoff

21

1 reference

28 July 2017

Elena Shumay

22

1 reference

28 July 2017

Michael Schueller

23

1 reference

28 July 2017

Donald Warner

24

1 reference

28 July 2017

Karen Apelskog-Torres

25

1 reference

28 July 2017

language of work or name

English

0 references

publication date

4 November 2009

1 reference

28 July 2017

published in

Neuropsychopharmacology

1 reference

28 July 2017

volume

35

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

623-631

1 reference

https://scigraph.springernature.com/pub.10.1038/npp.2009.167

28 July 2017

exact match

0 references

cites work

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Major depression: emerging therapeutics

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Monoamine oxidase inactivation: from pathophysiology to therapeutics

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Brain monoamine oxidase A activity predicts trait aggression

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Designing new treatments for depression and anxiety

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Projections of global mortality and burden of disease from 2002 to 2030

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Clinical pharmacology of MAO inhibitors: safety and future

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

PET and drug research and development

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Brain monoamine oxidase A inhibition in cigarette smokers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Clinical pharmacology of monoamine oxidase inhibitors.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

On tyramine, food, beverages and the reversible MAO inhibitor moclobemide

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327

14 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2009.167

Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2009.167

In vivo molecular imaging biomarkers: clinical pharmacology's new "PET"?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Non-MAO A binding of clorgyline in white matter in human brain

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Plasma input function determination for PET using a commercial laboratory robot.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833271

Monoamine oxidase inhibitors and the cheese effect

30 October 2018

1 reference

12 December 2020

Monoamine oxidase A and B activities in heavy smokers

1 reference

12 December 2020

Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs

1 reference

12 December 2020

Clorgyline. A new treatment for patients with refractory rapid-cycling disorder

1 reference

12 December 2020

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

12 December 2020

Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal

1 reference

12 December 2020

Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2009.167

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NPP.2009.167

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference